IL-17A Regulates The Development Of Hepatocellular Carcinoma Through Autophagy Pathway

Background:Hepatocellular carcinoma(HCC)has been a serious health problem all over the world.It is the fifth most frequent neoplasm,and the third most common cause of cancer-related death.However,along with the development of the treatment against HCC,Its high metastasis and recurrence also restrict the outcome of HCC patients is still poor.HCC is frequently the long-term result of chronic liver inflammation.Recent studies highlight new molecular mechanisms involved in HCC development and progression,including immune cells and their secreted cytokines.Several inflammatory cytokines are currently known to take part in the promotion of HCC.Interleukin(IL)17A is a proinflammatory cytokine mainly secreted by T helper(Th)17 cells.However,the role of IL-17A in the development and progression of HCC remains controversial.Some studies have demonstrated that IL-17A could inhibit the starvation-induced autophagy.And the exchange of autophagy also exert effects on HCC biologic activity.In this study,we aimed to establish whether IL-17A can influence the pathophysiological progression of HCC,which is regulated by autophagy,and to clarify the underlying mechanism.IL-17A may be a possible therapeutic target against this disease.Objectives:This study aims to establish whether IL-17A can influence the pathophysiological progression of HCC,which is regulated by autophagy,and to clarify the underlying mechanism in vitro.The expression of IL-17A and autophagy related protein in HCC specimens after resection were detected,and then clarified the statistic relationship among IL-17A,autophagy and the development of HCC.Methods:The expression and prognostic value of IL-17 A and autophagic gene Beclin1 were determined in 83 HCC patients after resection,using immunohistochemistry.The effects and underlying molecular mechanisms of IL-17A on human HCC were explored in vitro using recombinant human IL-17A.Western blotting was performed to detect the expression of cell autophagy,apoptosis and migration.Immunofluorescence was used to detect the LC3B foci dots and morphology of nuclear.CCK-8 assay was used to examine the cell viability.Wound healing assay and Transwell were used to investigate the cell migration of the HCC cells.Results:High expression of IL-17A and low expression of Beclin-1 were obviously associated with worse TNM stage in HCC patients.And the level of autophagy was lower in tumor tissues compared with tumor-adjacent tissues.In vitro,recombinant human IL-17A inhibited starvation-induced autophagy and maintained cell viability through activating TAK1-binding protein 2(TAB2)-and TAB3(TAK1-binding protein 3(TAB3)-inducing p38 mitogen-activated protein kinase(MAPK)in Huh-7 and HepG 2 HCC cells.IL-17A promoted migration of HCC cells through the TAB2/p38 MAPK and TAB3/p38 MAPK pathways as well.Conclusion:In vitro,IL-17A inhibited autophagy through phosphorylation of p38 MAPK by elevating expression of TAB2 and TAB3,thus increasing the toleration of HCC cells to starvation,and decreasing the level of autophagic cell death.We showed that high expression of IL-17A and autophagy-related gene Beclin-1 was associated with poor clinical outcome of HCC after tumor resection.Autophagy was lower only in IL-17A positive tumor tissue.